Hemcheck Sweden AB (publ) publishes the Annual Report for 2016 – Regulatory
This Press Release should not be released or distributed, directly or indirectly, within USA, Canada, Japan, Australia, Hong Kong, Switzerland, Singapore, South Africa, New Zealand or any other jurisdictions where distribution would be subject to legal restrictions.
Hemcheck Sweden AB (publ) announces today that the company publishes the annual report for 2016. The annual report is available in Swedish on the company’s website www.hemcheck.com and via the attached PDF.
About hemCheck:
Hemcheck Sweden is a medical technology company addressing the issue of hemolysis (the rupturing of red blood cells) – the most common reason for blood samples to be deemed unfit for laboratory analysis. Hemcheck Sweden is doing this by developing and commercializing a novel product concept (HELGE(TM) and READY(TM)) that detects hemolyzed blood samples at the point of care. Hemcheck Sweden was founded in 2010 and is headquartered in Karlstad, Sweden.
Contact
hemCheck Sweden AB (publ)
Annelie Brolinson, CEO
Tel: +46 70 288 0826
E-post: annelie.brolinson@hemcheck.com
Universitetsgatan 2
651 88 Karlstad
www.hemcheck.com
Important information
This is information which hemCheck is required to disclose according to EU Market Abuse Regulation law. The information was provided by the above contact person’s auspices, for publication on 28th of April 2017, 09:00.
